Clinical Waste Solutions Limited 04508250 false 2024-09-01 2025-08-31 2025-08-31 The principal activity of the company is low grade clinical waste disposal Digita Accounts Production Advanced 6.30.9574.0 true 04508250 2024-09-01 2025-08-31 04508250 2025-08-31 04508250 bus:OrdinaryShareClass1 2025-08-31 04508250 core:RetainedEarningsAccumulatedLosses 2025-08-31 04508250 core:ShareCapital 2025-08-31 04508250 core:CurrentFinancialInstruments 2025-08-31 04508250 core:CurrentFinancialInstruments core:WithinOneYear 2025-08-31 04508250 core:Non-currentFinancialInstruments core:AfterOneYear 2025-08-31 04508250 core:FurnitureFittings 2025-08-31 04508250 core:MotorVehicles 2025-08-31 04508250 core:OfficeEquipment 2025-08-31 04508250 core:PlantMachinery 2025-08-31 04508250 bus:SmallEntities 2024-09-01 2025-08-31 04508250 bus:AuditExemptWithAccountantsReport 2024-09-01 2025-08-31 04508250 bus:FilletedAccounts 2024-09-01 2025-08-31 04508250 bus:SmallCompaniesRegimeForAccounts 2024-09-01 2025-08-31 04508250 bus:RegisteredOffice 2024-09-01 2025-08-31 04508250 bus:CompanySecretary1 2024-09-01 2025-08-31 04508250 bus:Director2 2024-09-01 2025-08-31 04508250 bus:OrdinaryShareClass1 2024-09-01 2025-08-31 04508250 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 04508250 bus:Agent1 2024-09-01 2025-08-31 04508250 core:ComputerSoftware 2024-09-01 2025-08-31 04508250 core:ComputerEquipment 2024-09-01 2025-08-31 04508250 core:FurnitureFittings 2024-09-01 2025-08-31 04508250 core:MotorVehicles 2024-09-01 2025-08-31 04508250 core:OfficeEquipment 2024-09-01 2025-08-31 04508250 core:PlantMachinery 2024-09-01 2025-08-31 04508250 countries:EnglandWales 2024-09-01 2025-08-31 04508250 2024-08-31 04508250 core:FurnitureFittings 2024-08-31 04508250 core:MotorVehicles 2024-08-31 04508250 core:OfficeEquipment 2024-08-31 04508250 core:PlantMachinery 2024-08-31 04508250 2023-09-01 2024-08-31 04508250 2024-08-31 04508250 bus:OrdinaryShareClass1 2024-08-31 04508250 core:RetainedEarningsAccumulatedLosses 2024-08-31 04508250 core:ShareCapital 2024-08-31 04508250 core:CurrentFinancialInstruments 2024-08-31 04508250 core:CurrentFinancialInstruments core:WithinOneYear 2024-08-31 04508250 core:Non-currentFinancialInstruments core:AfterOneYear 2024-08-31 04508250 core:FurnitureFittings 2024-08-31 04508250 core:MotorVehicles 2024-08-31 04508250 core:OfficeEquipment 2024-08-31 04508250 core:PlantMachinery 2024-08-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 04508250

Clinical Waste Solutions Limited

Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 August 2025

 

Clinical Waste Solutions Limited

Contents

Company Information

1

Abridged Balance Sheet

2 to 3

Notes to the Unaudited Abridged Financial Statements

4 to 8

 

Clinical Waste Solutions Limited

Company Information

Director

Mr GJ Moore

Company secretary

Ward Goodman Company Services Limited

Registered office

4 Cedar Park
Cobham Road
Ferndown Industrial Estate
Wimborne
Dorset
BH21 7SF

Accountants

Ward Goodman Accountancy Services Ltd
Chartered Certified Accountants4 Cedar Park
Cobham Road
Ferndown Industrial Estate
Wimborne
Dorset
BH21 7SF

 

Clinical Waste Solutions Limited

(Registration number: 04508250)
Abridged Balance Sheet as at 31 August 2025

Note

2025
£

2024
£

Fixed assets

 

Intangible assets

4

-

1,234

Tangible assets

5

1,687,006

1,419,487

 

1,687,006

1,420,721

Current assets

 

Stocks

6

11,000

11,000

Debtors

386,544

379,048

Cash at bank and in hand

 

189,095

219,405

 

586,639

609,453

Prepayments and accrued income

 

32,884

13,866

Creditors: Amounts falling due within one year

(820,335)

(823,972)

Net current liabilities

 

(200,812)

(200,653)

Total assets less current liabilities

 

1,486,194

1,220,068

Creditors: Amounts falling due after more than one year

(477,169)

(441,596)

Provisions for liabilities

(365,610)

(285,856)

Accruals and deferred income

 

(41,565)

(19,000)

Net assets

 

601,850

473,616

Capital and reserves

 

Called up share capital

7

1

1

Retained earnings

601,849

473,615

Shareholders' funds

 

601,850

473,616

For the financial year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

 

Clinical Waste Solutions Limited

(Registration number: 04508250)
Abridged Balance Sheet as at 31 August 2025

Approved and authorised by the director on 21 April 2026
 

.........................................
Mr GJ Moore
Director

 

Clinical Waste Solutions Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 August 2025

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
4 Cedar Park
Cobham Road
Ferndown Industrial Estate
Wimborne
Dorset
BH21 7SF
United Kingdom

These financial statements were authorised for issue by the director on 21 April 2026.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The financial statements are presented in Pound Sterling and rounded to the nearest £1.

Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

 

Clinical Waste Solutions Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 August 2025

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and machinery

20% on reducing balance

Fixtures and fittings

20% on reducing balance

Motor vehicles

20% on reducing balance

Computer equipment

33% on cost

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Computer software

straight line over 3 years

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

 

Clinical Waste Solutions Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 August 2025

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.

Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the balance sheet as a finance lease obligation.

Lease payments are apportioned between finance costs in the profit and loss account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 10 (2024 - 12).

4

Intangible assets

Total
£

Cost or valuation

At 1 September 2024

57,340

At 31 August 2025

57,340

Amortisation

At 1 September 2024

56,106

Amortisation charge

1,234

At 31 August 2025

57,340

Carrying amount

At 31 August 2025

-

At 31 August 2024

1,234

 

Clinical Waste Solutions Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 August 2025

5

Tangible assets

Fixtures and fittings
£

Plant and machinery
£

Office equipment
£

Motor vehicles
 £

Total
£

Cost or valuation

At 1 September 2024

37,419

1,899,450

17,232

690,277

2,644,378

Additions

260

3,842

-

443,965

448,067

Disposals

-

-

-

(119,091)

(119,091)

At 31 August 2025

37,679

1,903,292

17,232

1,015,151

2,973,354

Depreciation

At 1 September 2024

25,122

690,023

16,249

493,497

1,224,891

Charge for the year

2,486

115,944

617

52,556

171,603

Eliminated on disposal

-

-

-

(110,146)

(110,146)

At 31 August 2025

27,608

805,967

16,866

435,907

1,286,348

Carrying amount

At 31 August 2025

10,071

1,097,325

366

579,244

1,687,006

At 31 August 2024

12,297

1,209,427

983

196,780

1,419,487

 

Clinical Waste Solutions Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 August 2025

6

Stocks

2025
£

2024
£

Other inventories

11,000

11,000

7

Share capital

Allotted, called up and fully paid shares

2025

2024

No.

£

No.

£

Allotted, issued and fully paid of £1 each

1

1

1

1

       

8

Financial commitments, guarantees and contingencies

Amounts disclosed in the balance sheet

Included in the balance sheet are financial commitments of £961,431 (2024 - £858,380). At the year end the company had other financial commitments owing to Funding Circle of £6,164 (2024: £76,682), Premium Credit of £30,477 (2024:£nil), a Government backed CBIL of £7,500 (2024: £17,500) and hire purchase liabilities of £917,290 (2024: £764,198).

The hire purchase liabilities are secured against the assets in which they relate to.